Durchdewald Moritz, Guinea-Viniegra Juan, Haag Daniel, Riehl Astrid, Lichter Peter, Hahn Meinhard, Wagner Erwin F, Angel Peter, Hess Jochen
Division of Transduction and Growth Control, German Cancer Research Center, Heidelberg, Germany.
Cancer Res. 2008 Sep 1;68(17):6877-83. doi: 10.1158/0008-5472.CAN-08-0299.
Expression and function of the oncogenic transcription factor activator protein (AP-1; mainly composed of Jun and Fos proteins) is required for neoplastic transformation of keratinocytes in vitro and tumor promotion as well as malignant progression in vivo. Here, we describe the identification of 372 differentially expressed genes comparing skin tumor samples of K5-SOS-F transgenic mice (Fos(f/f) SOS(+)) with samples derived from animals with a specific deletion of c-Fos in keratinocytes (Fos(Deltaep) SOS(+)). Fos-dependent transcription of selected genes was confirmed by quantitative real-time PCR analysis using tumor samples and mouse back skin treated with the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA). One of the most differentially expressed genes encodes the small mucin-like glycoprotein Podoplanin (Pdpn), whose expression correlates with malignant progression in mouse tumor model systems and human cancer. We found Pdpn and Fos expression in chemically induced mouse skin tumors, and detailed analysis of the Pdpn gene promoter revealed impaired activity in Fos-deficient mouse embryonic fibroblasts, which could be restored by ectopic Fos expression. Direct Fos protein binding to the Pdpn promoter was shown by chromatin immunoprecipitation and a TPA-induced complex at a TPA-responsive element-like motif in the proximal promoter was identified by electrophoretic mobility shift assays. In summary, we could define a Fos-dependent genetic program in a well-established model of skin tumors. Systematic analysis of these novel target genes will guide us in elucidating the molecular mechanisms of AP-1-regulated pathways that are critically implicated in neoplastic transformation and/or malignant progression.
致癌转录因子激活蛋白(AP-1;主要由Jun和Fos蛋白组成)的表达和功能是角质形成细胞体外肿瘤转化、体内肿瘤促进以及恶性进展所必需的。在此,我们描述了对372个差异表达基因的鉴定,这些基因是通过比较K5-SOS-F转基因小鼠(Fos(f/f) SOS(+))的皮肤肿瘤样本与角质形成细胞中c-Fos特异性缺失的动物(Fos(Deltaep) SOS(+))的样本得出的。使用肿瘤样本和经肿瘤启动子12-O-十四烷酰佛波醇-13-乙酸酯(TPA)处理的小鼠背部皮肤,通过定量实时PCR分析证实了所选基因的Fos依赖性转录。差异表达最显著的基因之一编码小粘蛋白样糖蛋白血小板结合蛋白(Pdpn),其表达与小鼠肿瘤模型系统和人类癌症中的恶性进展相关。我们在化学诱导的小鼠皮肤肿瘤中发现了Pdpn和Fos的表达,对Pdpn基因启动子的详细分析显示,在Fos缺陷的小鼠胚胎成纤维细胞中其活性受损,而异位表达Fos可恢复该活性。通过染色质免疫沉淀显示Fos蛋白直接与Pdpn启动子结合,并通过电泳迁移率变动分析在近端启动子中一个类似TPA反应元件的基序处鉴定出TPA诱导的复合物。总之,我们可以在一个成熟的皮肤肿瘤模型中定义一个Fos依赖性遗传程序。对这些新的靶基因进行系统分析将指导我们阐明AP-1调节通路的分子机制,这些通路与肿瘤转化和/或恶性进展密切相关。